Cargando…
Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice
BACKGROUND: The FDA-approved small-molecule drug ibrutinib is an effective targeted therapy for patients with chronic lymphocytic leukemia (CLL). Ibrutinib inhibits Bruton’s tyrosine kinase (BTK), a kinase involved in B cell receptor signaling. However, the potential regulation of neuroinflammatory...
Autores principales: | Nam, Hye Yeon, Nam, Jin Han, Yoon, Gwangho, Lee, Ju-Young, Nam, Youngpyo, Kang, Hye-Jin, Cho, Hyun-Ji, Kim, Jeongyeon, Hoe, Hyang-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145206/ https://www.ncbi.nlm.nih.gov/pubmed/30231870 http://dx.doi.org/10.1186/s12974-018-1308-0 |
Ejemplares similares
-
The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
por: Lee, Ju-Young, et al.
Publicado: (2018) -
Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling
por: Ryu, Ka-Young, et al.
Publicado: (2019) -
An Aqueous Extract of Herbal Medicine ALWPs Enhances Cognitive Performance and Inhibits LPS-Induced Neuroinflammation via FAK/NF-κB Signaling Pathways
por: Lee, Ju-Young, et al.
Publicado: (2018) -
Sorafenib Modulates the LPS- and Aβ-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice
por: Kim, Jieun, et al.
Publicado: (2021) -
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells
por: Kim, Dong-Cheol, et al.
Publicado: (2016)